HomeCompareALGN vs PSX

ALGN vs PSX: Dividend Comparison 2026

ALGN yields 1.20% · PSX yields 2.64%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PSX wins by $29.0K in total portfolio value
10 years
ALGN
ALGN
● Live price
1.20%
Share price
$166.26
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$130.06
Full ALGN calculator →
PSX
PSX
● Live price
2.64%
Share price
$184.81
Annual div
$4.87
5Y div CAGR
32.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$50.4K
Annual income
$8,982.50
Full PSX calculator →

Portfolio growth — ALGN vs PSX

📍 PSX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALGNPSX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALGN + PSX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALGN pays
PSX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALGN
Annual income on $10K today (after 15% tax)
$102.25/yr
After 10yr DRIP, annual income (after tax)
$110.55/yr
PSX
Annual income on $10K today (after 15% tax)
$223.99/yr
After 10yr DRIP, annual income (after tax)
$7,635.13/yr
At 15% tax rate, PSX beats the other by $7,524.57/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALGN + PSX for your $10,000?

ALGN: 50%PSX: 50%
100% PSX50/50100% ALGN
Portfolio after 10yr
$35.9K
Annual income
$4,556.28/yr
Blended yield
12.69%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ALGN right now

ALGN
Analyst Ratings
24
Buy
7
Hold
2
Sell
Consensus: Buy
Price Target
$197.30
+18.7% upside vs current
Range: $140.00 — $220.00
Altman Z
4.9
Piotroski
7/9
PSX
Analyst Ratings
18
Buy
15
Hold
2
Sell
Consensus: Buy
Price Target
$156.50
-15.3% upside vs current
Range: $140.00 — $172.00
Altman Z
3.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALGN buys
0
PSX buys
0
No recent congressional trades found for ALGN or PSX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALGNPSX
Forward yield1.20%2.64%
Annual dividend / share$2.00$4.87
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.1%
Portfolio after 10y$21.4K$50.4K
Annual income after 10y$130.06$8,982.50
Total dividends collected$1.3K$26.7K
Payment frequencyquarterlyquarterly
SectorStockEnergy
Analyst consensusBuyBuy
Analyst price target$197.30$156.50

Year-by-year: ALGN vs PSX ($10,000, DRIP)

YearALGN PortfolioALGN Income/yrPSX PortfolioPSX Income/yrGap
1← crossover$10,820$120.29$11,048$348.10$228.00PSX
2$11,699$121.65$12,296$474.80$597.00PSX
3$12,641$122.92$13,809$652.41$1.2KPSX
4$13,650$124.13$15,681$904.56$2.0KPSX
5$14,731$125.27$18,046$1,268.08$3.3KPSX
6$15,889$126.34$21,111$1,801.74$5.2KPSX
7$17,128$127.36$25,191$2,602.17$8.1KPSX
8$18,455$128.31$30,788$3,833.46$12.3KPSX
9$19,876$129.21$38,728$5,784.19$18.9KPSX
10$21,398$130.06$50,421$8,982.50$29.0KPSX

ALGN vs PSX: Complete Analysis 2026

ALGNStock

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Full ALGN Calculator →

PSXEnergy

Phillips 66 operates as an energy manufacturing and logistics company. It operates through four segments: Midstream, Chemicals, Refining, and Marketing and Specialties (M&S). The Midstream segment transports crude oil and other feedstocks; delivers refined petroleum products to market; provides terminaling and storage services for crude oil and refined petroleum products; transports, stores, fractionates, exports, and markets natural gas liquids; provides other fee-based processing services; and gathers, processes, transports, and markets natural gas. The Chemicals segment produces and markets ethylene and other olefin products; aromatics and styrenics products, such as benzene, cyclohexane, styrene, and polystyrene; and various specialty chemical products, including organosulfur chemicals, solvents, catalysts, and chemicals used in drilling and mining. The Refining segment refines crude oil and other feedstocks into petroleum products, such as gasolines, distillates, aviation, and renewable fuels at 12 refineries in the United States and Europe. The M&S segment purchases for resale and markets refined petroleum products, including gasolines, distillates, and aviation fuels primarily in the United States and Europe. This segment also manufactures and markets specialty products, such as base oils and lubricants. The company was founded in 1875 and is headquartered in Houston, Texas.

Full PSX Calculator →
📬

Get this ALGN vs PSX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALGN vs SCHDALGN vs JEPIALGN vs OALGN vs KOALGN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.